Page 6 - Vu University Medical Center News Today : Breaking News, Live Updates & Top Stories | Vimarsana
ImmunoBrain Checkpoint Awarded $5 Million US NIA Grant for Phase 1b Alzheimer s Disease Proof-of-Mechanism Study of Anti-PD-L1 IBC-Ab002
biospace.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospace.com Daily Mail and Mail on Sunday newspapers.
El pesacado azul, lucha contra el alzheimer
lasprovincias.es - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lasprovincias.es Daily Mail and Mail on Sunday newspapers.
New Arkansas Law--and Similar Bills--Endanger Transgender Youth, Research Shows
scientificamerican.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from scientificamerican.com Daily Mail and Mail on Sunday newspapers.
Contrary to arguments by critics, a University of Utah-led study found that legalizing physician-assisted suicide in Oregon and the Netherlands did not result in a disproportionate number of deaths among the elderly, poor, women, minorities, uninsured, minors, chronically ill, less educated or psychiatric patients.
Of 10 “vulnerable groups” examined in the study, only AIDS patients used doctor-assisted suicide at elevated rates.
“Fears about the impact on vulnerable people have dominated debate about physician-assisted suicide. We find no evidence to support those fears where this practice already is legal,” says the study’s lead author, bioethicist Margaret Battin, a University of Utah distinguished professor of philosophy and adjunct professor of internal medicine.
Bruno Dubois
Bruno Dubois is currently Professor of Neurology at the Neurological Institute of the Salpétrière University Hospital at Paris, University Pierre et Marie Curie Paris VI. He is Director of the Behavioural Neurology Department and of the Dementia Research Center at the Hospital. He is also Director of the Research Unit Inserm U-610 of the ICM (Institut du Cerveau et de la Moelle Epinière) of the Hospital. He is coordinator of the National Reference Center on Rare Dementias and of the National Reference Center for young-onset Alzheimer patients. He is President of the Scientific Committee of France-Alzheimer and of IFRAD (International Fund Raising for Alzheimer s disease), consultant for the Human Frontier Program and Expert of the French Agency of Drugs. He is a member of the European Alzheimer Disease Consortium (EADC). He has published on anatomical and biochemical studies on the central cholinergic systems in rodents and humans; on cognitive neuropharmacology; an